The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 69.41%.However, over the last six months, we can see a weaker performance of 116.34%. Over the last 30 days, the price of TVTX has fallen by 53.37%. And in the last five days, it has surged by 8.71%.
Travere Therapeutics Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $15.36 on 10/04/24 and a low of $5.12 for the same time frame on 04/25/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of TVTX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Travere Therapeutics Inc’s current trading price is -0.85% away from its 52-week high, while its distance from the 52-week low is 197.46%. The stock’s price range during this period has varied between$5.12 and $15.36. The Travere Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 3.18 million for the day, a figure considerably higher than their average daily volume of 1.52 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Travere Therapeutics Inc (TVTX) has experienced a quarterly rise of 74.66% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.16B and boasts a workforce of 380 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.53, with a change in price of +8.89. Similarly, Travere Therapeutics Inc recorded 1,406,805 in trading volume during the last 100 days, posting a change of +140.22%.
TVTX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TVTX stands at 26.62. Similarly, the long-term debt-to-equity ratio is also 26.27.
TVTX Stock Stochastic Average
As of today, Travere Therapeutics Inc’s raw stochastic average for the last 50 days stands at 96.95%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 94.19%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 77.61% and 75.34%, respectively.
